DFTX compared with XENE: revenue, margins and what each company keeps, and the suppliers and customers both name

DFTXDefinium Therapeutics, Inc.

Mkt capRevenueRevenue

XENEXenon Pharmaceuticals Inc.

Mkt capRevenueRevenue

Compare

DFTXDefinium Therapeutics, Inc.

XENEXenon Pharmaceuticals Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

DFTX

0 of 3at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±20.9%0.00%×0.00

May 8 '26±9.7%▼−4.96%×0.52

Q1 FY26±12.9%▲+0.93%×0.07

Jan 12 '26—▲+0.29%—

XENE

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±9.1%▼−1.84%×0.20

May 8 '26±10.3%▲+0.79%×0.08

= impliedDFTX realized, solidXENE realized, hatchedOne scale, both sides: full bar = 31%× = |realized| ÷ impliedSource: market data

Q1 FY26

±30.3%

▼−3.76%

×0.13

Nov 4 '25±8.7%▼−4.94%×0.56

DFTXDefinium Therapeutics, Inc.

33.27▲+9.57%· post 33.05

Mkt cap$4.5BRevenue—

XENEXenon Pharmaceuticals Inc.

39.15▲+3.90%· post 39.07

ClosedNov 6 '26

Mkt cap$3.8BRevenue$8MQ1 FY25

Compare

ClosedNov 6 '26

DFTXDefinium Therapeutics, Inc.

XENEXenon Pharmaceuticals Inc.

33.27▲+9.57%post 33.05

Price

39.15▲+3.90%post 39.07

$4.5B

Mkt cap

$3.8B

—

Revenue

$8MQ1 FY25

DFTX33.27▲+9.57%vsXENE39.15▲+3.90%ClosedNov 6 '26